FMR LLC held its stake in shares of Vermillion, Inc. (NASDAQ:VRML) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,252,463 shares of the company’s stock at the end of the first quarter. FMR LLC owned 9.36% of Vermillion worth $10,978,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Greenwich Wealth Management LLC bought a new stake in shares of Vermillion during the first quarter worth $276,000. M&T Bank Corp raised its stake in shares of Vermillion by 48.2% in the first quarter. M&T Bank Corp now owns 230,500 shares of the company’s stock worth $482,000 after buying an additional 75,000 shares in the last quarter. Finally, Birchview Capital LP raised its stake in shares of Vermillion by 1.3% in the first quarter. Birchview Capital LP now owns 2,752,933 shares of the company’s stock worth $5,649,000 after buying an additional 35,419 shares in the last quarter. Hedge funds and other institutional investors own 36.44% of the company’s stock.
Vermillion, Inc. (VRML) opened at 1.32 on Friday. The company’s market cap is $74.04 million. The stock’s 50 day moving average is $1.66 and its 200 day moving average is $1.81. Vermillion, Inc. has a 1-year low of $0.76 and a 1-year high of $2.85.
Vermillion (NASDAQ:VRML) last announced its quarterly earnings data on Wednesday, August 9th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.04). Vermillion had a negative net margin of 370.69% and a negative return on equity of 205.71%. The company had revenue of $0.90 million during the quarter. Equities analysts anticipate that Vermillion, Inc. will post ($0.16) earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Fmr LLC Has $10,978,000 Position in Vermillion, Inc. (VRML)” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.com-unik.info/2017/08/12/vermillion-inc-vrml-stake-maintained-by-fmr-llc-updated-updated.html.
Separately, ValuEngine lowered shares of Vermillion from a “hold” rating to a “sell” rating in a research report on Friday, July 28th.
Vermillion Company Profile
Vermillion, Inc is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician’s clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery.
What are top analysts saying about Vermillion Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Vermillion Inc. and related companies.